803 related articles for article (PubMed ID: 32401997)
1. Frequency of first and second-line drug resistance-associated mutations among resistant Mycobacterium tuberculosis clinical isolates from São Paulo, Brazil.
Matsui T; Pinhata JMW; Rabello MCDS; Brandão AP; Ferrazoli L; Leão SC; Viana-Niero C; Oliveira RS
Mem Inst Oswaldo Cruz; 2020; 115():e200055. PubMed ID: 32401997
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of mutations associated with resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients from high prevalence tuberculosis city in Morocco.
Oudghiri A; Karimi H; Chetioui F; Zakham F; Bourkadi JE; Elmessaoudi MD; Laglaoui A; Chaoui I; El Mzibri M
BMC Infect Dis; 2018 Feb; 18(1):98. PubMed ID: 29486710
[TBL] [Abstract][Full Text] [Related]
3. Characterisation of drug resistance-associated mutations among clinical multidrug-resistant Mycobacterium tuberculosis isolates from Hebei Province, China.
Li Q; Wang Y; Li Y; Gao H; Zhang Z; Feng F; Dai E
J Glob Antimicrob Resist; 2019 Sep; 18():168-176. PubMed ID: 30926465
[TBL] [Abstract][Full Text] [Related]
4. Whole-genome sequencing of clinical isolates from tuberculosis patients in India: real-world data indicates a high proportion of pre-XDR cases.
Bhanushali A; Atre S; Nair P; Thandaseery GA; Shah S; Kuruwa S; Zade A; Nikam C; Gomare M; Chatterjee A
Microbiol Spectr; 2024 May; 12(5):e0277023. PubMed ID: 38597637
[TBL] [Abstract][Full Text] [Related]
5. First insights into circulating XDR and pre-XDR Mycobacterium tuberculosis in Southern Brazil.
Salvato RS; Costa ERD; Reis AJ; Schiefelbein SH; Halon ML; Barcellos RB; Unis G; Dias CF; Viveiros M; Portugal I; da Silva PEA; Kritski AL; Perdigão J; Rossetti MLR
Infect Genet Evol; 2020 Mar; 78():104127. PubMed ID: 31783187
[TBL] [Abstract][Full Text] [Related]
6. Drug-resistant Mycobacterium tuberculosis among Nepalese patients at a tuberculosis referral center.
Chand AB; Basnet A; Maharjan B; Rai G; Joshi YP; Bhatt LR; Sen B; Rai SK
PLoS One; 2024; 19(5):e0301210. PubMed ID: 38709710
[TBL] [Abstract][Full Text] [Related]
7. Evolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates from KwaZulu-Natal.
Cohen KA; Abeel T; Manson McGuire A; Desjardins CA; Munsamy V; Shea TP; Walker BJ; Bantubani N; Almeida DV; Alvarado L; Chapman SB; Mvelase NR; Duffy EY; Fitzgerald MG; Govender P; Gujja S; Hamilton S; Howarth C; Larimer JD; Maharaj K; Pearson MD; Priest ME; Zeng Q; Padayatchi N; Grosset J; Young SK; Wortman J; Mlisana KP; O'Donnell MR; Birren BW; Bishai WR; Pym AS; Earl AM
PLoS Med; 2015 Sep; 12(9):e1001880. PubMed ID: 26418737
[TBL] [Abstract][Full Text] [Related]
8. Extensively drug-resistant tuberculosis in Myanmar: burden and mutations causing second-line drug resistance.
Ei PW; Aung WW; Nyunt WW; Swe TL; Htwe MM; Win SM; Aung ST; Chang CL; Lee HY; Lee JS
Int J Tuberc Lung Dis; 2018 Jan; 22(1):47-53. PubMed ID: 29297425
[TBL] [Abstract][Full Text] [Related]
9. Early detection of multidrug- and pre-extensively drug-resistant tuberculosis from smear-positive sputum by direct sequencing.
Chen J; Peng P; Du Y; Ren Y; Chen L; Rao Y; Wang W
BMC Infect Dis; 2017 Apr; 17(1):300. PubMed ID: 28438132
[TBL] [Abstract][Full Text] [Related]
10. Molecular characterization of multidrug-resistant Mycobacterium tuberculosis isolates from high prevalence tuberculosis states in Mexico.
Juarez-Eusebio DM; Munro-Rojas D; Muñiz-Salazar R; Laniado-Laborín R; Martinez-Guarneros JA; Flores-López CA; Zenteno-Cuevas R
Infect Genet Evol; 2017 Nov; 55():384-391. PubMed ID: 27637930
[TBL] [Abstract][Full Text] [Related]
11. A descriptive study on isoniazid resistance-associated mutations, clustering and treatment outcomes of drug-resistant tuberculosis in a high burden country.
Pinhata JMW; Ferrazoli L; Mendes FF; Gonçalves MG; Rabello MCDS; Ghisi KT; Simonsen V; Cavalin RF; Lindoso AABP; de Oliveira RS
Eur J Clin Microbiol Infect Dis; 2024 Jan; 43(1):73-85. PubMed ID: 37943394
[TBL] [Abstract][Full Text] [Related]
12. Second-line anti-tuberculosis drug resistance and its genetic determinants in multidrug-resistant Mycobacterium tuberculosis clinical isolates.
Bakuła Z; Napiórkowska A; Kamiński M; Augustynowicz-Kopeć E; Zwolska Z; Bielecki J; Jagielski T
J Microbiol Immunol Infect; 2016 Jun; 49(3):439-44. PubMed ID: 26117528
[TBL] [Abstract][Full Text] [Related]
13. Frequency and patterns of second-line resistance conferring mutations among MDR-TB isolates resistant to a second-line drug from eSwatini, Somalia and Uganda (2014-2016).
Kateete DP; Kamulegeya R; Kigozi E; Katabazi FA; Lukoye D; Sebit SI; Abdi H; Arube P; Kasule GW; Musisi K; Dlamini MG; Khumalo D; Joloba ML
BMC Pulm Med; 2019 Jul; 19(1):124. PubMed ID: 31291943
[TBL] [Abstract][Full Text] [Related]
14. Redefining MDR-TB: Comparison of Mycobacterium tuberculosis clinical isolates from Russia and Taiwan.
Jou R; Lee WT; Kulagina EV; Weng JY; Isakova AI; Lin WH; Antonova OV; Wu MH; Arslanbaeva LR; Tasi HY; Nosova EY; Zimenkov DV
Infect Genet Evol; 2019 Aug; 72():141-146. PubMed ID: 30593924
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of isoniazid resistance-conferring mutations associated with multidrug-resistant tuberculosis in Free State Province, South Africa.
Pitso L; Potgieter S; Van der Spoel van Dijk A
S Afr Med J; 2019 Aug; 109(9):659-664. PubMed ID: 31635590
[TBL] [Abstract][Full Text] [Related]
16. Prevalence, associated factors, outcomes and transmission of extensively drug-resistant tuberculosis among multidrug-resistant tuberculosis patients in São Paulo, Brazil: a cross-sectional study.
Gallo JF; Pinhata JMW; Simonsen V; Galesi VMN; Ferrazoli L; Oliveira RS
Clin Microbiol Infect; 2018 Aug; 24(8):889-895. PubMed ID: 29175351
[TBL] [Abstract][Full Text] [Related]
17. High Prevalence of inhA Promoter Mutations among Patients with Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa.
Niehaus AJ; Mlisana K; Gandhi NR; Mathema B; Brust JC
PLoS One; 2015; 10(9):e0135003. PubMed ID: 26332235
[TBL] [Abstract][Full Text] [Related]
18. Correlating genetic mutations with isoniazid phenotypic levels of resistance in Mycobacterium tuberculosis isolates from patients with drug-resistant tuberculosis in a high burden setting.
Pinhata JMW; Brandao AP; Mendes FF; Rabello MCDS; Ferrazoli L; de Oliveira RS
Eur J Clin Microbiol Infect Dis; 2021 Dec; 40(12):2551-2561. PubMed ID: 34297229
[TBL] [Abstract][Full Text] [Related]
19. Mycobacterial interspersed repetitive unit typing and mutational profile for multidrug-resistant and extensively drug-resistant tuberculosis surveillance in Portugal: a 3-year period overview.
Silva C; Perdigão J; Jordão L; Portugal I
Int J Antimicrob Agents; 2014 Dec; 44(6):546-51. PubMed ID: 25270633
[TBL] [Abstract][Full Text] [Related]
20. Genotypic and phenotypic drug resistance patterns of Mycobacterium tuberculosis isolated from presumptive pulmonary tuberculosis patients in Ethiopia: A multicenter study.
Yenew B; Kebede A; Alemu A; Diriba G; Mehammed Z; Amare M; Dagne B; Sinshaw W; Tesfaye E; Beyene D; Abegaz WE
PLoS One; 2024; 19(5):e0303460. PubMed ID: 38753615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
